Dermato-oncology
The sponsor is involved in clinical research for locally advanced and metastatic squamous cell carcinoma of the skin, with interest in immune checkpoint therapy and treatment strategies for advanced cutaneous malignancies.
- Nivolumab
- Relatlimab
- RECIST 1.1
These activities reflect a focus on solid tumor management in skin cancer, including disease control and response assessment in advanced dermatologic oncology.
Skin and soft tissue infection
The sponsor also supports research in acute bacterial skin and skin structure infection, including erysipelas and limited cellulitis, with attention to early treatment pathways in outpatient care.
- Dalbavancin
- Outpatient therapy
- Cellulitis
This area centers on antibacterial treatment for gram-positive skin infections and clinical management of uncomplicated soft tissue infection.
